Ann Surg Treat Res.  2014 Mar;86(3):143-151. 10.4174/astr.2014.86.3.143.

Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection

• Ryuk JP
• Choi GS
• Park JS
• Kim HJ
• Park SY
• Yoon GS
• Jun SH
• Kwon YC

• KMID: 2266895
• DOI: http://doi.org/10.4174/astr.2014.86.3.143

Abstract

PURPOSE
Because predicting recurrence intervals and patterns would allow for appropriate therapeutic strategies, we evaluated the clinical and pathological characteristics of early and late recurrences of colorectal cancer.
METHODS
Patients who developed recurrence after undergoing curative resection for colorectal cancer stage I-III between January 2000 and May 2006 were identified. Early recurrence was defined as recurrence within 2 years after primary surgery of colorectal cancer. Analyses were performed to compare the clinicopathological characteristics and overall survival rate between the early and late recurrence groups.
RESULTS
One hundred fifty-eight patients experienced early recurrence and 64 had late recurrence. Multivariate analysis revealed that the postoperative elevation of carbohydrate antigen 19-9 (CA 19-9), venous invasion, and N stage correlated with the recurrence interval. The liver was the most common site of early recurrence (40.5%), whereas late recurrence was more common locally (28.1%), or in the lung (32.8%). The 5-year overall survival rates for early and late recurrence were significantly different (34.7% vs. 78.8%; P < 0.001). Survival rates after the surgical resection of recurrent lesions were not different between the two groups.
CONCLUSION
Early recurrence within 2 years after surgery was associated with poor survival outcomes after colorectal cancer recurrence. An elevated postoperative CA 19-9 level, venous invasion, and advanced N stage were found to be significant risk factors for early recurrence of colorectal cancer.

Keyword

Colorectal neoplasms; Recurrence interval; Risk factors; Recurrence; Survival

MeSH Terms

Colorectal Neoplasms*
Humans
Liver
Lung
Multivariate Analysis
Prognosis*
Recurrence*
Risk Factors
Survival Rate

Figure

• 

  Fig. 1 The overall survival curves for patients with colorectal cancer according to the recurrence interval. (A) Overall survival using a cutoff time of 2 years. (B). Overall survival after recurrence. (C) Overall survival after recurrence among patients undergoing repeated resection.

Reference

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon (FR): International Agency for Research on Cancer;c2014. cited 2013 Jan 31. Available from: http://globocan.iarc.fr.

2. Ministry of Health and Welfare. The Korea central cancer registry. Annual Report of Cancer Incidence in 2008. Seoul: Ministry for Health and Welfare;2010.

3. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg. 1994; 81:7–19.

4. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002; 324:813.

5. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005; 23:8512–8519.

6. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol. 2005; 16:756–761.

7. Longo WE, Johnson FE. The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am. 2002; 82:1091–1108.

8. Kaiser AM, Kang JC, Chan LS, Beart RW. The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer. Colorectal Dis. 2006; 8:696–703.

9. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003; 3:26.

10. Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum. 2001; 44:173–178.

11. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer;2010.

12. Cho YB, Chun HK, Yun HR, Lee WS, Yun SH, Lee WY. Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection. Dis Colon Rectum. 2007; 50:1204–1210.

13. Aghili M, Izadi S, Madani H, Mortazavi H. Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer. Asia Pac J Clin Oncol. 2010; 6:35–41.

14. Tsai HL, Chu KS, Huang YH, Su YC, Wu JY, Kuo CH, et al. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol. 2009; 100:736–743.

15. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery. 2007; 141:67–75.

16. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts JM, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum. 1994; 37:875–881.

17. Tsai HL, Cheng KI, Lu CY, Kuo CH, Ma CJ, Wu JY, et al. Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J Surg Oncol. 2008; 97:383–387.

18. Yakabe T, Nakafusa Y, Sumi K, Miyoshi A, Kitajima Y, Sato S, et al. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. Ann Surg Oncol. 2010; 17:2349–2356.

19. Holubec L Jr, Topolcan O, Pikner R, Pecen L, Holubec Sen L, Finek J, et al. Criteria for the selection of referential groups in tumor marker statistical evaluation on the basis of a retrospective study. Anticancer Res. 2003; 23(2A):865–870.

20. Morita S, Nomura T, Fukushima Y, Morimoto T, Hiraoka N, Shibata N. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer? Dis Colon Rectum. 2004; 47:227–232.

21. Park IJ, Choi GS, Jun SH. Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer. Anticancer Res. 2009; 29:4303–4308.

22. Yu H, Son GM, Joh YG. The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer. J Korean Surg Soc. 2013; 84:231–237.

23. Dabelsteen E. Cell surface carbohydrates as prognos t ic ma rker s in human carcinomas. J Pathol. 1996; 179:358–369.

24. Fujita S, Shimoda T, Yoshimura K, Yamamoto S, Akasu T, Moriya Y. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection. J Surg Oncol. 2003; 84:127–131.

25. Bentzen SM, Balslev I, Pedersen M, Teglbjaerg PS, Hanberg-Sorensen F, Bone J, et al. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy: a multivariate regression analysis. Br J Cancer. 1992; 65:102–107.

26. Jung SH, Kim HC, Kim AY, Choi PW, Park IJ, Yu CS, et al. Colorectal cancer presenting as an early recurrence within 1 year after a curative resection. J Korean Soc Coloproctol. 2008; 24:265–272.

27. Kobayashi H, Mochizuki H, Morita T, Kotake K, Teramoto T, Kameoka S, et al. Timing of relapse and outcome after curative resection for colorectal cancer: a Japanese multicenter study. Dig Surg. 2009; 26:249–255.

28. Yie SM, Lou B, Ye SR, Cao M, He X, Li P, et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol. 2008; 15:3073–3082.

29. Lee SY, Min KS, Chung JK, Jung IM, Ahn YJ, Hwang KT, et al. Carcinoembryonic antigen level of draining venous blood as a predictor of recurrence in colorectal cancer patient. J Korean Surg Soc. 2011; 81:387–393.

30. Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010; 36:470–476.